CrushSCI.com
211.5平均天数
217中位天数
43最短天数
354最长天数
742025发文量

Paper Review Records

全部论文审稿周期

15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

170 天

Clinical response to systemic AAV gene therapy in a large animal model of late-stage lysosomal storage disease

作者
Jacqueline E. Hunter; Caitlyn M. Molony; Dana L. Clarke; Wojciech Panek; Charles H. Vite; Sanjeev Chawla; Harish Poptani; John H. Wolfe展开收起
作者单位
1. Research Institute of Children’s Hospital of Philadelphia, Philadelphia, USA; 2. W.F. Goodman Center for Comparative Medical Genetics, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, USA; 3. Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, USA; 4. Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA; 5. Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK; 6. Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA展开收起
PDF源文件 DOI 网页
43 天

Antimicrobial resistance and gene therapy: emerging molecular strategies for a global health threat

作者
A. Vitiello; M. Boccellino; A. Zovi; M. Bassetti展开收起
作者单位
1. Department of Health Prevention, Research and Emergencies, Italian Ministry of Health, Rome, Italy; 2. Università Link Campus di Roma, Rome, Italy; 3. Department of One health, italian Ministry of health, Roma, Italy; 4. University of Genova, Clinical Infectious Diseases Unit, San Martino Polyclinic Hospital-IRCCS, Genoa, Italy展开收起
PDF源文件 DOI 网页
341 天

The poly-(HA-GMA) hydrogel carrying AAV8-sTβRII alleviates scar formation in mice skin wound healing by inhibiting fibrosis

作者
Jinhao Chen; Lijun Zhan; Jinyan Duan; Tianning Wang; Zenan Meng; Qianru Wang; Jianlin Yang; Xiaofei Huang; Yue Liao; Xinyu Song; Chunyu Cao展开收起
作者单位
1. Hubei Provincial Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, China; 2. Affiliated Renhe Hospital of China Three Gorges University, Yichang, China; 3. Clinical Medical Research Center for Precision Diagnosis and Treatment of Lung Cancer and Management of Advanced Cancer Pain of Hubei Province, the First College of Clinical Medical Science, China Three Gorges University, Yichang, China展开收起
PDF源文件 DOI 网页
202 天

First-in-human nuclease-free homologous recombination-dependent gene editing in pediatric patients with methylmalonic acidemia: results of a phase 1/2 study

作者
Jirair K. Bedoyan; Thomas Morgan; Angela Sun; Hong Li; Daniel Gruskin; Marie Payton; Frederic Chereau; Eugene Scott Swenson; Qun Lin; Mark A. Kay; Jerry Vockley展开收起
作者单位
1. UPMC Children’s Hospital of Pittsburgh, Pittsburgh, USA; 2. University of Pittsburgh School of Medicine, Pittsburgh, USA; 3. Vanderbilt University School of Medicine, Nashville, USA; 4. Seattle Children’s Hospital, Seattle, USA; 5. Emory University, Atlanta, USA; 6. LogicBio Therapeutics, Lexington, USA; 7. Alexion, AstraZeneca Rare Disease, Boston, USA; 8. Stanford University, Stanford, USA展开收起
PDF源文件 DOI 网页
225 天

Building a gene editing lexicon: a model for rare and inherited disorders

作者
Leonard A. Valentino; Cedric Hermans; Donna Coffin; Wolfgang Miesbach; Maria Elisa Mancuso; Carmen Unzu; Micheala Jones; David E. Gutstein; William McKeown; Craig M. Kessler展开收起
作者单位
1. World Federation of Hemophilia USA, Albany, USA; 2. Hemophilia and Thrombophilia Center, Rush University Medical Center, Chicago, USA; 3. Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium; 4. Department of Data and Research, World Federation of Hemophilia, Montréal, Canada; 5. Department of Haemostaseology, University Hospital Frankfurt, Frankfurt, Germany; 6. Center for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital, Rozzano, Italy; 7. Humanitas University, Pieve Emanuele, Italy; 8. DNA&RNA Medicine Division, CIMA-Universidad de Navarra, Pamplona, Spain; 9. Regeneron Pharmaceuticals, Inc., Tarrytown, USA; 10. Care of Elderly Medicine, Antrim Area Hospital, Antrim, UK; 11. Hemophilia and Thrombophilia Comprehensive Treatment Center, Georgetown University Medical Center, Washington, USA展开收起
PDF源文件 DOI 网页
230 天

Topical application of Cas9 ribonucleoproteins inhibits corneal neovascularization in a mouse model of alkali burn injury

作者
Seok Jae Lee; Bae-Geun Nam; Sung-Ah Hong; Dong Hyun Jo; Sang-Mok Lee; Sangsu Bae; Jeong Hun Kim展开收起
作者单位
1. Fight against Angiogenesis-Related Blindness (FARB) Laboratory, Clinical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; 2. Global Excellence Center for Gene & Cell Therapy (GEC-GCT), Seoul National University Hospital, Seoul, Republic of Korea; 3. Department of Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea; 4. Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; 5. Divison of Bio Research, SK Bioscience, Seongnam-si, Republic of Korea; 6. Department of Anatomy & Cell Biology, Seoul National University College of Medicine, Seoul, Republic of Korea; 7. Department of Cornea, External Disease & Refractive Surgery, HanGil Eye Hospital, Incheon, Republic of Korea; 8. Department of Ophthalmology, Catholic Kwandong University College of Medicine, Gangneung-si, Republic of Korea; 9. Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea; 10. Institute of Reproductive Medicine and Population, Seoul National University College of Medicine, Seoul, Republic of Korea展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿62 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 [email protected]

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。